Nebraska Medicaid

Does Nebraska Medicaid cover Ozempic?

Quick answer · Type 2 Diabetes

Nebraska Medicaid covers Ozempic for type 2 diabetes with prior authorization on Medicaid.

  • Medicaid: Covered (preferred drug). Diagnosis documented with a code

Last verified June 4, 2026. Policy effective June 1, 2026. Source: NE_PDL-20260601.pdf. How we verify this data →

Check your card for your exact plan →

Ozempic for Type 2 Diabetes

What Nebraska Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered (preferred drug)

What you need to qualify

  • Diagnosis documented with a code
  • Trial of metformin for at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication", "ASCVD"])

Qualification pathways

You can qualify through any one of these.

Preferred Agent: Type 2 Diabetes with Metformin Trial

All of:

  • Diagnosis of Type II diabetes

Plus any one of:

  • Trial and failure of metformin
  • Intolerance to metformin

Preferred Agent: Type 2 Diabetes with ASCVD (no metformin trial required)

All of:

  • Diagnosis of Type II diabetes
  • Diagnosis of ASCVD associated with Type II diabetes

Documentation to bring

  • Documentation of Type II diabetes diagnosis
  • Documentation of metformin trial and failure or intolerance, OR documentation of ASCVD associated with Type II diabetes

Policy note: Ozempic appears on BOTH the Preferred and Non-Preferred lists. As a preferred agent, it requires T2DM diagnosis plus metformin trial/failure/intolerance, OR T2DM with ASCVD (no metformin trial required). The document also lists Ozempic as a non-preferred agent with notation 'AL, NR, QTAB' — this likely refers to a specific formulation (tablet/oral form, i.e., Rybelsus-like oral semaglutide) or a second listing; the non-preferred criteria require failure of TWO preferred GLP-1 RA agents, HbA1C ≥ 7, and metformin trial or contraindication/intolerance. The preferred injectable Ozempic (semaglutide) pen is captured here. Age limit (AL) and quantity limit (QL) are noted but specific values are not detailed in this document excerpt. The document includes an 'AL' flag indicating an age limit applies, but the specific age threshold is not stated in the provided text.

Policy effective June 1, 2026 · verified June 4, 2026 · source: NE_PDL-20260601.pdf

Why Ozempic requests get denied by Nebraska Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Ozempic and Wegovy are the same molecule with different approved uses; a request for Ozempic under a diagnosis that matches Wegovy is routinely denied.
  2. Diagnosis code missing or wrong on the request.
  3. No documented metformin trial (dose, dates, and outcome) or a stated reason it can't be used.

Frequently asked questions

Does Nebraska Medicaid cover Ozempic?
Nebraska Medicaid covers Ozempic for type 2 diabetes with prior authorization on Medicaid.
Do you have to try metformin before Ozempic?
Yes for type 2 diabetes: Nebraska Medicaid requires a documented trial of metformin of at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication", "ASCVD"]).
How current is this information?
This page reflects Nebraska Medicaid's written policy as of June 1, 2026, last verified against the source document on June 4, 2026.

Other medications under Nebraska Medicaid

Ozempic coverage under other plans

All insurance plans · All medications

This page summarizes Nebraska Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.